Skip to main content
Premium Trial:

Request an Annual Quote

Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech

NEW YORK – Lithuanian biotech company Atrandi Biosciences said on Tuesday that it has raised $4.8 million in venture capital to advance the global commercialization of its microfluidic and single-cell analysis technologies.

The Vilnius-based firm, formerly called Droplet Genomics, will also use the funds to establish a team to support US-based customers.

Vsquared Ventures led the funding round, with participation from Practica Capital and Metaplanet, bringing the total capital raised by the company to over $8 million.

Atrandi launched Styx, a droplet-based, benchtop high-throughput screening platform, last year. Styx complements the company's Onyx platform for next-generation sequencing library generation and functional assays.

Atrandi's semipermeable capsule technology addresses limitations in conventional microfluidics, such as high cost, limited applicability to different workflow types, and a limited number of single-cell data points.

"With our new semipermeable capsule technology, we overcome these limitations and give scientists the tools necessary to fully unleash the potential of single-cell experiments, next-generation genome sequencing, AI-driven drug discovery, or personalized medicine," Juozas Nainys, CEO of Atrandi, said in a statement.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.